Receptos, Inc.
(NASDAQ : RCPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
-0.55%45.551.4%$856.77m
JNJJohnson & Johnson
-1.05%137.070.7%$781.42m
PFEPfizer Inc.
-1.42%39.320.9%$758.74m
MRKMerck & Co., Inc.
-0.58%73.490.6%$739.37m
LLYEli Lilly and Company
-0.88%115.481.0%$723.13m
ABBVAbbVie, Inc.
-0.41%77.662.2%$381.26m
AZNAstraZeneca PLC Sponsored ADR
0.10%38.811.3%$239.45m
NVSNovartis AG Sponsored ADR
-1.12%76.440.2%$227.75m
GSKGlaxoSmithKline plc Sponsored ADR
-0.16%39.920.2%$99.92m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.11%48.460.1%$66.79m
SNYSanofi Sponsored ADR
0.28%41.200.2%$39.55m
LCILannett Company, Inc.
2.99%7.2436.7%$7.96m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.97%3.081.6%$1.07m
EPIXESSA Pharma Inc
-9.57%2.280.1%$0.02m

Company Profile

Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in Delaware.